Parts a and b are reproduced from Valles, F. et al

Slides:

Advertisements

Similar presentations

Viruses are used for gene therapy

Advertisements

© Oxford University Press How are the plates moving?

The American Journal of Occupational Therapy

Gene therapy for heart failure

Algorithm for guideline-directed medical therapy for patients with stable ischemic heart disease. The use of bile acid sequestrant is relatively contraindicated.

Hypothetical distribution of test results for healthy and diseased individuals. The position of the "cutoff point" between "normal" and "abnormal" (or.

Predicted 5-year benefits of LDL cholesterol reductions with statin treatment at different levels of risk. (A) Major vascular events, and (B) vascular.

The American Journal of Occupational Therapy

Adapted with permission from Hsia, J et al

Hepatic AAV Gene Transfer and the Immune System: Friends or Foes?

Figure 4 BMI and mortality in patients with heart failure

Should we irradiate a brain tumor in a patient with parkinsonism

Understanding EMPA-REG OUTCOME

Athena Philis-Tsimikas, MD The American Journal of Medicine

Metabolic Complications in Elderly Adults With CKD

Catherine M. Meyers, MD, Josephine P. Briggs, MD

New Hope for a MicroRNA Therapy for Liver Cancer

Gene Therapy: Past, Present, and Future

Nat. Rev. Neurol. doi: /nrneurol

Figure 6 Imaging methods used to study Parkinson disease

Evidence Supporting Idarucizumab for the Reversal of Dabigatran

Pioneering a Global Cure for Chronic Hepatitis C Virus Infection

73 Cents: A Mural American Journal of Kidney Diseases

Figure 1 Clinical correlates of neurodegeneration in MS

Approach to the Treatment of Methanol Intoxication

Parkinson's disease and anaesthesia

Should we irradiate a brain tumor in a patient with parkinsonism

Volume 16, Issue 4, Pages (April 2008)

Understanding EMPA-REG OUTCOME

Volume 18, Issue 12, Pages (December 2010)

Part a is adapted from Gilmore, J. H. et al

Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: an open-label, phase 1/2 trial Yin-Hsiu Chien,

Treating Liver Fibrosis: (Re)Programmed to Succeed

Healing Genes in the Nervous System

Volume 14, Issue 1, Pages (July 2006)

Engineering Viral Genomes: Adeno-Associated Vectors

Figure 7 Corneal tissue engineering

This Month in AJKD American Journal of Kidney Diseases

Joseph A. Vassalotti, MD, Lesley A. Stevens, MD, MS, Andrew S

Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin? O.A. Cornely Clinical Microbiology and.

A New Era of Renal Denervation Trials for Patients With Hypertension?

This Month in AJKD American Journal of Kidney Diseases

Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.

Raymond T Bartus, Marc S Weinberg, R. Jude Samulski Molecular Therapy

Glucose Metabolism: A Sweet Relief of Alzheimer’s Disease

Gyongyi Szabo, Peter Sarnow, Shashi Bala Journal of Hepatology

847. Eradication of Therapy-Resistant Human Prostate Tumors Using an Ultrasound Guided Site-Specific Cancer Terminator Virus Delivery Approach Molecular.

Jeffrey Perl, MD, FRCP(C), Christopher T. Chan, MD, FRCP(C)

Bob Djavan European Urology Supplements

Reducing antibiotic use in influenza: challenges and rewards

Volume 16, Issue 6, Pages (June 2008)

The Neuro-Urological Connection

Volume 18, Issue 3, Pages (March 2010)

372. Targeted Mutagenesis of Ubiquitin-Binding Lysine Residues on the Adeno- Associated Virus (AAV)2 Capsid Improves Its Transduction Efficiency Molecular.

521. AAV Immunotherapy Induces Functional Antigen Specific Regulatory T-Cells to a Neuroantigen: A Potential Treatment for MS Brad E. Hoffman Molecular.

Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits? Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,

Screen capture of web map application (with the exploratory layer of frequency counts of campaigns per forward sortation area (FSA) displayed). Screen.

Figure 4 Treponema pallidum invasion

Fig. 3 ACID isosurfaces of the model complex 2′ separated into the π- and σ-contribution. ACID isosurfaces of the model complex 2′ separated into the π-

Molecular Therapy - Methods & Clinical Development

Volume 18, Issue 8, Pages (August 2010)

Exploring the Use of Adeno-Associated Virus for Gene Therapy

Fig. 1 Schematic subcategorization of AAV in three clinically relevant disease categories defined by clinical ... Fig. 1 Schematic subcategorization of.

Volume 21, Issue 1, Pages (January 2013)

J Bone Miner Res 2014;doi: /jbmr.2325 (Fig. 2)

Zhijian Wu, Aravind Asokan, R. Jude Samulski Molecular Therapy

Making New Connections—Chromosome Conformation Capture for Identification of Disease-Associated Target Genes Matthew T. Patrick, Lam C. Tsoi, Johann.

Frédéric Michard, MD, PhD, Apurva Badheka, MD

Nat. Rev. Mater. doi: /natrevmats

Baseline New York Heart Association functional class (NYHA FC) predicts survival in patients with pulmonary hypertension using infused epoprostenol therapy.

Presentation transcript:

Parts a and b are reproduced from Valles, F. et al Parts a and b are reproduced from Valles, F. et al. Qualitative imaging of adeno-associated virus serotype 2–human aromatic L-amino acid decarboxylase gene therapy in a phase I study for the treatment of Parkinson disease. Neurosurgery 2010, 67(5): 1377–1385, by permission of Oxford University Press (REF.228). Parts c and d adapted with permission from Journal of Controlled Release, 240, Bankiewicz, et al. AAV viral vector delivery to the brain by shape-conforming MR-guided infusions, 434–442, Copyright (2016), with permission from Elsevier (REF.229).